Our focus in on Life Sciences. We specialize in services that support Bio/Pharmaceutical, and Combination Device companies. Our clients range from venture-backed to global public companies.
Since 2015 we have supported more than 40 companies with services including regulatory strategy, clinical development, pipeline and portfolio optimization, M&A due diligence and compliance and training. We can help companies, scientifically, strategically or operationally to:
Navigate complex and frequently changing regulations
Engage and interact with regulatory agencies
Guide companies through the entire drug development process
Support your due diligence
Assess organizational effectiveness
ABOUT AYD BIOPHARMA CONSULTING GROUP, LLC
A NOTE FROM OUR FOUNDER
Sharon W. Ayd, Ph.D., MBA
Founder & Chief Executive Officer
Sharon Ayd, Ph.D., MBA, is a senior, international operations executive with proven leadership in creating and operationally implementing corporate strategy for highly competitive multi-national Biopharmaceutical companies.
Dr. Ayd is the former Global Vice President, Innovation & Development of Fresenius-Kabi (DAX:FRE) a $7B global healthcare company based in Frankfurt, Germany. Previously, Sharon was Global Vice President, Research & Development of Hospira/Pfizer (NYSE:HSP) a $4.5B provider of pharmaceuticals and medical devices.